Doctor profile · Federal record
Dr. KATHERINE BUCK, APRN-CNP
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · Gynecologic Oncology Physician · NORMAN, OK
- NPI 1659772986
- Accepts Medicare
- MIPS 71.7 / 100 · 2023
- 12 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
225 E MOSIER ST
NORMAN, OK 730697883
(918) 691-4777 - Mailing address
-
800 NE 10TH ST
OKLAHOMA CITY, OK 731045418
Credentials & registration
- NPI registered
- September 2014 — 12 yrs on file
- Profile last updated
- January 23, 2019
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Oklahoma #89559
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659772986. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
509
Distinct HCPCS
4
Medicare allowed
$34,361
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 264 | 163 | $53 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 148 | 72 | $78 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 73 | 38 | $117 | |
G0444 |
Annual depression screening, 5 to 15 minutes | 24 | 24 | $7 |
In context: peer comparison
Among 24 peers in this city , average services per provider: 104. This provider delivers 4.9× the peer median.Open Payments
Industry payments received
All-time total
$1,921
Transactions
62
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $493.89 | |
| Gilead Sciences, Inc. | 2 | $223.29 | |
| Astellas Pharma US Inc | 4 | $192.51 | |
| Daiichi Sankyo Inc. | 7 | $160.47 | |
| Merck Sharp & Dohme LLC | 9 | $150.45 | |
| Genmab U.S., Inc. | 4 | $149.74 | |
| GlaxoSmithKline, LLC. | 6 | $149.05 | |
| Lilly USA, LLC | 5 | $84.17 | |
| Genentech USA, Inc. | 3 | $55.97 | |
| TerSera Therapeutics LLC | 2 | $47.81 | |
| Tempus AI, Inc | 2 | $47.56 | |
| Myriad Genetic Laboratories, Inc. | 2 | $29.07 | |
| Phathom Pharmaceuticals, Inc. | 2 | $27.61 | |
| EMD Serono, Inc. | 1 | $27.06 | |
| Novo Nordisk Inc | 1 | $24.63 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
118
Patients
0
Total drug cost
$9,198
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 21 | 0 | $192 |
| Amlodipine Besylate | Generic | 16 | 0 | $57 |
| Letrozole | Generic | 16 | 0 | $252 |
| Prochlorperazine Maleate | Generic | 15 | 0 | $327 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 14 | 0 | $222 |
| Eliquis (Apixaban) | Brand | 13 | 0 | $7,915 |
| Ondansetron Odt (Ondansetron) | Brand | 12 | 0 | $195 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 11 | 0 | $38 |